Immorta Bio’s technologies aim to provide your own young stem cells and your own enhanced immune cells to deal with cancers or diseases of aging the way your body dealt with them when you were young and healthy.
Conventional therapies are mediocre at best in treating diseases of aging. Immorta Bio’s approach, leveraging your younger body’s own natural mechanisms, aims at not only treating diseases of aging, but also potentially opening a door to significant healthy life extension.
Aging is the ultimate risk factor for many diseases, marked by progressive deterioration of organs and tissues and an enhanced risk of disease initiation and progression including cancer, cardiovascular disease, metabolic disorders and neurodegeneration. Conventional treatments for diseases associated with aging often provide only symptomatic relief and fail to address the underlying causes of aging.
Existing stem-cell based solutions have limitations, ranging from the absence of personalized sources of "young" cells capable of replacing aging or senescent cells in various, affected organs to largely targeting only one physiological pathway or molecule. Treating aging itself, rather than just the diseases it causes, offers a comprehensive approach to improving health outcomes, increasing longevity, and extending lifespan.
Immorta Bio is focused on two primary technology paths that have to date generated three platforms:
· Cellular Rejuvenation: This technology has generated two platforms (PPCX and PMSC) of patient-specific “immortal” stem cells from their blood. These stem cells can be differentiated into young cells in unlimited quantity. Introduced into damaged or aged organ they rejuvenate surrounding cells, as well as the whole organ itself. Both platforms are applicable to multiple indications.
· Senolytic Immunotherapy: The SenoVax™ (SNVX) platform, generated from the patient’s blood and skin punch biopsy, consists of the precision targeted immune cells that enhance the body’s innate ability to self-heal. SenoVax™ is applicable to multiple cancers as well as to organ rejuvenation.
Stem Cell Revivify™: rejuvenation of a damaged organ to the healthy state
using Immorta Bio Innovative Solution
At Immorta Bio, we maintain exclusive marketing rights for our innovative therapeutic programs and are currently raising funds to advance clinical trials, upgrade lab facilities, and support ongoing research and development for our rejuvenation programs. We seek strategic partnerships to maximize their commercial potential, typically after reaching the proof-of-efficacy stage. Contact us to explore collaboration opportunities.
Immorta Bio embodies a team-centric ethos, comprising highly devoted and skilled individuals. Our collaborative teams operate synergistically within a dynamic, enjoyable, and creatively fulfilling environment. Upholding principles of high integrity, mutual respect, teamwork, open-mindedness, and scientific excellence, we prioritize recruiting, developing, and retaining individuals possessing the determination and expertise essential for success.
We provide compelling career opportunities for individuals passionate about life extension and dedicated to supporting advancements in the biotechnology field.